Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment.
Nociti
V
V
Frisullo
G
G
Tartaglione
T
T
Patanella
A K
AK
Iorio
R
R
Tonali
P A
PA
Batocchi
A P
AP
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis / Q000097:blood*; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D001379:Azathioprine / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D002524:Cerebellar Ataxia / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000276:immunology; D004829:Epilepsy, Generalized / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D005260:Female; D005968:Glutamate Decarboxylase / Q000276:immunology*; D050031:Hashimoto Disease / Q000150:complications / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009759:Nystagmus, Pathologic / Q000150:complications / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome; D014806:Vitamin B 12 Deficiency / Q000150:complications / Q000276:immunology; D005680:gamma-Aminobutyric Acid / Q000096:biosynthesis / Q000172:deficiency
D000927:Anticonvulsants; D001323:Autoantibodies; D015415:Biomarkers; D007166:Immunosuppressive Agents; D005680:gamma-Aminobutyric Acid; D005968:Glutamate Decarboxylase; D001379:Azathioprine; D011241:Prednisone